New Research Reveals How Alzheimer's Disease Affects Multiple Body Systems

New research uncovers how Alzheimer's disease proteins impact aging, metabolism, and gut health, revealing systemic effects beyond the brain.
Research indicates that Alzheimer's disease impacts not only the brain but also influences aging, fat metabolism, and gut health. A recent study using fruit flies shows that proteins linked to Alzheimer's, such as amyloid-beta and tau, can accelerate biological aging and cause widespread effects on organs beyond the nervous system. The study uncovered mechanisms involving systemic inflammation, metabolic changes, and communication pathways between the brain and peripheral tissues. These findings suggest that Alzheimer's is a systemic disease with effects extending to various body functions, highlighting the importance of holistic approaches to understanding and potentially treating the condition.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Rethinking the Necessity of Six-Monthly Dental Check-Ups and Cleanings
Recent research indicates that routine dental check-ups every six months may not be necessary for everyone. Tailoring visit frequency based on individual risk factors can better support oral health and resource efficiency.
Long-term Study Reveals Disease Risk Surpasses Remission Status in Determining Transplant Outcomes for AML Patients
A groundbreaking long-term study shows that genetic risk factors, not remission status, are key to AML transplant success, challenging current treatment standards and emphasizing personalized approaches.
Rethinking Post-Illness Nutrition: Why Weight Loss and Alcohol Reduction Aren't Always Wise
Discover why traditional advice on weight loss and alcohol reduction may not always be helpful after illness, and learn about the importance of personalized nutrition strategies during recovery.
New Findings Show COVID-19 Can Persist in Cancer Patients and Impact Treatments
Research reveals that COVID-19 can persist in the gastrointestinal tissues of cancer patients long after infection, potentially affecting treatment outcomes and inflammation levels. Learn more about these groundbreaking findings from the University of Minnesota.



